Geneva Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $402K | Sell |
12,101
-450
| -4% | -$14.9K | 0.01% | 552 |
|
|
2017
Q1 | $403K | Sell |
12,551
-687
| -5% | -$22.1K | 0.01% | 541 |
|
|
2016
Q4 | $480K | Sell |
13,238
-8,444
| -39% | -$306K | 0.01% | 488 |
|
|
2016
Q3 | $998K | Sell |
21,682
-2,083
| -9% | -$95.9K | 0.02% | 318 |
|
|
2016
Q2 | $1.19M | Sell |
23,765
-8,328
| -26% | -$418K | 0.02% | 275 |
|
|
2016
Q1 | $1.72M | Buy |
32,093
+114
| +0.4% | +$6.1K | 0.03% | 212 |
|
|
2015
Q4 | $2.1M | Buy |
31,979
+19,359
| +153% | +$1.27M | 0.04% | 192 |
|
|
2015
Q3 | $713K | Sell |
12,620
-710
| -5% | -$40.1K | 0.01% | 339 |
|
|
2015
Q2 | $788K | Buy |
13,330
+119
| +0.9% | +$7.04K | 0.01% | 350 |
|
|
2015
Q1 | $823K | Sell |
13,211
-297
| -2% | -$18.5K | 0.01% | 336 |
|
|
2014
Q4 | $777K | Sell |
13,508
-3,442
| -20% | -$198K | 0.01% | 334 |
|
|
2014
Q3 | $911K | Buy |
16,950
+13
| +0.1% | +$699 | 0.02% | 323 |
|
|
2014
Q2 | $888K | Sell |
16,937
-28,615
| -63% | -$1.5M | 0.02% | 329 |
|
|
2014
Q1 | $2.41M | Buy |
45,552
+870
| +2% | +$46K | 0.04% | 189 |
|
|
2013
Q4 | $1.79M | Buy |
44,682
+14,250
| +47% | +$571K | 0.03% | 169 |
|
|
2013
Q3 | $1.15M | Buy |
30,432
+14,289
| +89% | +$540K | 0.02% | 235 |
|
|
2013
Q2 | $633K | Buy |
+16,143
| New | +$633K | 0.01% | 266 |
|